Fat attenuation index (FAI): a paradigm shift in cardiology.
Medscape Brazil have featured Dr Cheerag Shirodaria for his work within the industry.
Cheerag Shirodaria is a Cardiologist and Honorary Adviser to the Oxford University Hospitals NHS Foundation Trust in the United Kingdom. He is also co-founder and CEO of Caristo Diagnostics , a University of Oxford spinout company . Cheerag and team developed the Fat Attenuation Index (FAI ) , a non-invasive method to measure alterations that lead to atherosclerosis from the analysis of coronary CT angiography. In an interview with Medscape , Dr. Cheerag shared more details about the FAI.
You can read the full article on Medscape.
AI awards help build evidence base for technologies – health secretary
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
THE BIOTECHNOLOGY BOOM IN OXFORD: A LOOK AT 15 EXCITING STARTUPS
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…